We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Abstinence-Linked Money Management Multisite

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01327586
First Posted: April 1, 2011
Last Update Posted: July 17, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Yale University
  Purpose
Randomized clinical trial comparing a money management-based intervention involving storage and management of client funds, substance abuse counseling, and risk reduction counseling to individualized drug counseling.

Condition Intervention Phase
Dual Diagnosis Cocaine Abuse Cocaine Dependence Polysubstance Abuse Behavioral: ATM Behavioral: Individual Drug Counseling Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Abstinence-Linked Money Management Multisite

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Proportion of Urine toxicology tests without cocaine [ Time Frame: Month 0,1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ]

Secondary Outcome Measures:
  • Unprotected sexual encounters [ Time Frame: Month 0, 1,2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ]
    ACASI-measured


Enrollment: 108
Study Start Date: December 2009
Study Completion Date: January 2014
Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ATM
Advisor-Teller Money Manager
Behavioral: ATM
Weekly counseling focused on improving money management, abstaining from cocaine,and minimizing unprotected sex
Active Comparator: Individual Drug Counseling Behavioral: Individual Drug Counseling
Standard individualized drug counseling, modified from that described by Woody and colleagues

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Enrolled in ambulatory psychiatric treatment at one of the participating clinics
  • Receives SSI or SSDI payments
  • Able to provide written informed consent
  • Cocaine use within the last 60 days as evidenced by either a positive toxicology screen or self-reports

Exclusion Criteria:

  • Has a conservator of person
  • A history of violence towards clinical providers or predatory violence
  • Suicidal plans or intent; homicidal plans or intent. Suicidal or homicidal ideation will not be exclusion criteria
  • Physiological dependence on alcohol, illicit opiates or illicit sedatives as evidenced by a history of four weeks of daily use of these substances; and either tolerance or withdrawal (as defined by DSM IV-TR). The "standard withdrawal scales" referred to in DSM IV-TR will be the CIWA-AR (Sullivan et al., 1989) and the Clinical Opiate Withdrawal Scale (Wesson and Ling, 2003), with P.I. review because signs on the CIWA-AR such as "aware of sounds around you" may reflect psychiatric illness, not withdrawal
  • Will not be able to complete the twelve months of the study because of anticipated incarceration or move
  • Had been enrolled in the ongoing study
  • Unable to speak and understand English
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01327586


Locations
United States, Connecticut
Greater Bridgeport Mental Health Center
Bridgeport, Connecticut, United States, 06610
Capitol Region Mental Health Center
Hartford, Connecticut, United States, 06112
Sponsors and Collaborators
Yale University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Marc I Rosen, M.D. Yale University
  More Information

Additional Information:
Responsible Party: Yale University
ClinicalTrials.gov Identifier: NCT01327586     History of Changes
Other Study ID Numbers: R01DA12952 from VACHS account
First Submitted: February 2, 2011
First Posted: April 1, 2011
Last Update Posted: July 17, 2014
Last Verified: July 2014

Keywords provided by Yale University:
disability
substance abuse
cocaine abuse
dual diagnosis
representative payee
HIV risk reduction

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders